Expansion & Leadership ISCT is actively expanding activity through the Expanded Access Working Group with leadership additions such as a president elect and a new Chief Commercialization Officer, signaling growing focus on governance, strategy, and market access—opportunities to offer program management, stakeholder engagement, and commercialization services.

Global Collaboration The organization frequently partners with major industry groups (ARM, ASGCT) and issues joint statements and guidelines, indicating a receptive environment for alliance-building, sponsored initiatives, and Enterprise-level collaborations on policy, advocacy, and education platforms.

Education & Workforce Historical and ongoing investments in workforce development and training courses point to demand for learning management solutions, content platforms, and credentialing services to scale skills across the cell and gene therapy ecosystem.

Technology Stack Adoption of cloud, analytics, and CRM tools (AWS, Tableau, Qlik, iCIMS, QuickBooks Online, Mailchimp) suggests openness to integrated software solutions, data platforms, marketing automation, and member management enhancements.

Public Policy & Accessibility Active involvement in expanded access guidelines and policy-oriented initiatives creates opportunities to provide policy intelligence, compliance tooling, and program evaluation services that support accessibility, equity, and patient-centered outcomes.